Microorganism having improved ability to produce N-acetylglucosamine as a result of modulating glycolytic flux

US10724015B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10724015-B2
Application numberUS-201715598045-A
CountryUS
Kind codeB2
Filing dateMay 17, 2017
Priority dateMay 18, 2016
Publication dateJul 28, 2020
Grant dateJul 28, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a mutant microorganism in which a gene that encodes phosphofructokinase-2 is disrupted or deleted to reduce glycolytic flux to thereby improve the ability of the microorganism to produce N-acetylglucosamine, and to a method of producing N-acetylglucosamine using the mutant microorganism. The mutant microorganism according to the present invention has advantages in that it has high resistance to various chemical substances, grows rapidly, is easily cultured, and produces N-acetylglucosamine with high efficiency, indicating that it is useful for production of a large amount of N-acetylglucosamine.

First claim

Opening claim text (preview).

The invention claimed is: 1. A mutant Saccharomyces cerevisiae BY4742 that overproduces N-acetylglucosamine when cultured in the presence of galactose as a sole carbon source, said mutant Saccharomyces cerevisiae BY4742 comprising a gene encoding a mutant enzyme comprising the amino acid sequence of SEQ ID NO: 4, SEQ ID NO: 5, or SEQ ID NO: 6, wherein genes pfk26 and pfk27 which encode phosphofructokinase-2 (PFK-2) are disrupted or deleted, wherein the gene pfk26 has the nucleotide sequence of SEQ ID NO: 1 and the gene pfk27 has the nucleotide sequence of SEQ ID NO: 2, and wherein expression of the genes encoding phosphofructokinase-1 (PFK-1) and/or pyruvate kinase (Pyk1p) is inhibited, but not completely inactivated, said mutant Saccharomyces cerevisiae BY4742 comprising a Cas protein and/or a vector for expression of Cas protein, and guide RNA for reducing expression of said genes encoding phosphofructokinase-1 (PFK-1) and/or pyruvate kinase (Pyk1p), wherein said guide RNA comprises gRNA of SEQ ID NO: 10 for reducing expression of the gene encoding phosphofructokinase-1 (PFK-1) and/or gRNA of SEQ ID NO: 11 for reducing expression of the gene encoding pyruvate kinase (Pyk1p). 2. The mutant Saccharomyces cerevisiae of claim 1 , wherein a gene encoding HAD phosphatase YqaB represented by SEQ ID NO: 7 is introduced. 3. A method for producing N-acetylglucosamine, comprising the steps of: producing N-acetylglucosamine by culturing the mutant Saccharomyces cerevisiae of claim 1 ; and recovering the produced N-acetylglucosamine. 4. The method of claim 3 , wherein the mutant Saccharomyces cerevisiae is cultured in the presence of galactose as a carbon source. 5. The mutant Saccharomyces cerevisiae of claim 1 , wherein said Cas protein is Cas9. 6. The mutant Saccharomyces cerevisiae of claim 1 , wherein said Cas protein is in a Cas protein complex. 7. The mutant Saccharomyces cerevisiae of claim 1 , wherein said genes pfk26 and pfk27 are deleted. 8. The mutant Saccharomyces cerevisiae of claim 7 , wherein said Cas protein is Cas9. 9. The mutant Saccharomyces cerevisiae of claim 7 , wherein said Cas protein is in a Cas protein complex.

Assignees

Inventors

Classifications

  • transferring nitrogenous groups (2.6) · CPC title

  • Pyruvate kinase (2.7.1.40) · CPC title

  • Preparation of nitrogen-containing carbohydrates · CPC title

  • C12N9/1205Primary

    Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases · CPC title

  • 6-Phosphofructo-2-kinase (2.7.1.105) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10724015B2 cover?
The present invention relates to a mutant microorganism in which a gene that encodes phosphofructokinase-2 is disrupted or deleted to reduce glycolytic flux to thereby improve the ability of the microorganism to produce N-acetylglucosamine, and to a method of producing N-acetylglucosamine using the mutant microorganism. The mutant microorganism according to the present invention has advantages …
Who is the assignee on this patent?
Univ Korea Res & Bus Found
What technology area does this patent fall under?
Primary CPC classification C12N9/1205. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).